Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ocera Appoints Chief Development Officer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Ocera Appoints Chief Development Officer

Patni brings leadership experience from Roche, Novartis and Pfizer

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Rajiv Patni, M.D. has been appointed chief development officer at Ocera Therapeutics, Inc., effective September 2, 2014. Dr. Patni previously served as senior vice president for Actelion U.S. He also served as vice president at Roche and held leadership positions at Novartis and Pfizer.
 
“I am delighted to have Rajiv join our management team and expect that he will make significant contributions to the development of OCR-002,” said Linda Grais, M.D., chief executive officer of Ocera. “Rajiv has been involved in over 15 clinical development programs, across several therapeutic areas, including acute care indications. Rajiv also served as an academic physician and trained in internal medicine and cardiology. Rajiv’s experience both in the clinic and in industry will be an invaluable asset to Ocera.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters